Dexamethasone: The treatment that Trump received for Covid-19 has side effects. Forbes writer and highly credential science and health expert Bruce Y. Lee, offers an entertaining and insightful look at the Dexamethasone and its side effects. Lee points out that it is a corticosteroid, which is a class of steroid hormones…
Browsing: Therapeutics
Regeneron Pharmaceuticals, Inc. announced last week that its experimental two-antibody cocktail reduced viral levels and improved symptoms in non-hospitalized COVID-19 patients. The treatment, REGN-COV2, is also being studied for use in hospitalized patients, and for prevention of infection in people who have been exposed to COVID-19. The FDA can authorize…
FasterCures, a center of the Milken Institute, is currently tracking the development of treatments and vaccines for COVID-19 (coronavirus). This tracker contains an aggregation of publicly-available information from validated sources. According to Milken there are: 316 Treatments in 7 categories are being developed now. 212 Vaccines in development in 9…
Extensive Study in the UK involving 1,700 patients showed consistent benefits from steroid treatment. A new analysis of several studies in the UK which steroid drugs were used to determine effectiveness for treating COVID-19 found that they significantly reduced patient deaths, bolstering early, preliminary evidence for the benefit of these…
Opinion in the Wall Street Journal describes a Covid-19 therapy using “medicinal signaling cells,” or MSCs, which are found on blood vessels throughout the body. These cells eliminate the virus, calm the immune overreaction known as a cytokine storm, and repair damaged lung tissue. According to the author who is…
A common drug, already approved by the FDA, may also be a powerful tool in fighting COVID-19, according to research published this week. Heparin could be used as a decoy to prevent SARS-CoV-2 from infecting human cells. SARS-CoV-2, the virus that causes COVID-19, uses a surface spike protein to latch…
Abstract. A summary of a study provides the first in vivo evidence that zinc sulfate in combination with hydroxychloroquine may play a role in therapeutic management for COVID-19. As COVID-19 continues to spread, the mortality rate rises, as well as significant widespread economic losses. New potential therapies and means of…
Hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 according Henry Ford Health System. Of 2,541 patients hospitalized between March 10 and May 2, 2020 the study found 13% of those treated with hydroxychloroquine died compared to 26.4% not treated with hydroxychloroquine. The study was published today…